Concepedia

Publication | Open Access

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

DOIFull Paper Access

80

Citations

25

References

2015

Year

Markus Wallwiener, Andreas D. Hartkopf, Sabine Riethdorf, Juliane Nees, Martin R. Sprick, Birgitt Schönfisch, Florin‐Andrei Taran, Jörg Heil, Christof Sohn, Klaus Pantel,
BMC Cancer

Abstract

HER2 status can change during the course of breast cancer. CTC phenotyping may serve as an easy-to-perform "liquid biopsy" to reevaluate HER2 status and potentially guide treatment decisions. Further, prospective studies are needed.

References

YearCitations

Page 1